Phase II study of gemcitabine, doxorubicin and paclitaxel (GAT) as first-line chemotherapy for metastatic breast cancer: a translational research experience

Por Passardi, Alessandro, Massa, Ilaria, Zoli, Wainer, Gianni, Lorenzo, Milandri, Carlo, Zumaglini, Federica, Nanni, Oriana, Maltoni, Roberta, Frassineti, Giovanni Luca, Amadori, Dino
Publicado em 2006

Separate episodes of capillary leak syndrome and pulmonary hypertension after adjuvant gemcitabine and three years later after nab-paclitaxel for metastatic disease

Por Casadei Gardini, Andrea, Aquilina, Michele, Oboldi, Devil, Lucchesi, Alessandro, Carloni, Silvia, Tenti, Elena, Burgio, Marco Angelo, Amadori, Dino, Frassineti, Giovanni Luca
Publicado em 2013

MicroRNA profiling of primary pulmonary enteric adenocarcinoma in members from the same family reveals some similarities to pancreatic adenocarcinoma—a step towards personalized th...

Por Garajová, Ingrid, Funel, Niccola, Fiorentino, Michelangelo, Agostini, Valentina, Ferracin, Manuela, Negrini, Massimo, Frassineti, Giovanni Luca, Gavelli, Giampaolo, Frampton, Adam Enver, Biasco, Guido, Giovannetti, Elisa
Publicado no Clin Epigenetics (2015)

No evidence of NRAS mutation in squamous cell anal carcinoma (SCAC)

Por Capelli, Laura, Casadei Gardini, Andrea, Scarpi, Emanuela, Frassineti, Giovanni Luca, Saragoni, Luca, Puccetti, Maurizio, Scartozzi, Mario, Giannini, Massimo, Tamberi, Stefano, Corbelli, Jody, Ulivi, Paola
Publicado no Sci Rep (2016)

Impact of Pre-Treatment Lactate Dehydrogenase Levels on Prognosis and Bevacizumab Efficacy in Patients with Metastatic Colorectal Cancer

Por Passardi, Alessandro, Scarpi, Emanuela, Tamberi, Stefano, Cavanna, Luigi, Tassinari, Davide, Fontana, Annalisa, Pini, Sara, Bernardini, Ilaria, Accettura, Caterina, Ulivi, Paola, Frassineti, Giovanni Luca, Amadori, Dino
Publicado no PLoS One (2015)

Randomized phase II study with two gemcitabine- and docetaxel-based combinations as first-line chemotherapy for metastatic non-small cell lung cancer

Por Passardi, Alessandro, Cecconetto, Lorenzo, Dall'Agata, Monia, Dazzi, Claudio, Pasquini, Enzo, Oliverio, Giovanni, Zumaglini, Federica, Zoli, Wainer, Nanni, Oriana, Milandri, Carlo, Frassineti, Giovanni Luca, Amadori, Dino
Publicado em 2008

KRAS, BRAF and PIK3CA Status in Squamous Cell Anal Carcinoma (SCAC)

Por Casadei Gardini, Andrea, Capelli, Laura, Ulivi, Paola, Giannini, Massimo, Freier, Eva, Tamberi, Stefano, Scarpi, Emanuela, Passardi, Alassandro, Zoli, Wainer, Ragazzini, Angela, Amadori, Dino, Frassineti, Giovanni Luca
Publicado em 2014

eNOS polymorphisms as predictors of efficacy of bevacizumab-based chemotherapy in metastatic colorectal cancer: data from a randomized clinical trial

Por Ulivi, Paola, Scarpi, Emanuela, Passardi, Alessandro, Marisi, Giorgia, Calistri, Daniele, Zoli, Wainer, Del Re, Marzia, Frassineti, Giovanni Luca, Tassinari, Davide, Tamberi, Stefano, Vertogen, Bernadette, Amadori, Dino
Publicado no J Transl Med (2015)

Paraneoplastic lipase and amylase production in a patient with small-cell lung cancer: case report

Por Casadei Gardini, Andrea, Mariotti, Marita, Lucchesi, Alessandro, Pini, Sara, Valgiusti, Martina, Bravaccini, Sara, Del Monte, Angelo, Burgio, Marco Angelo, Marisi, Giorgia, Amadori, Dino, Frassineti, Giovanni Luca
Publicado no BMC Cancer (2016)

Efficacy of sorafenib in BRAF-mutated non-small-cell lung cancer (NSCLC) and no response in synchronous BRAF wild type-hepatocellular carcinoma: a case report

Por Casadei Gardini, Andrea, Chiadini, Elisa, Faloppi, Luca, Marisi, Giorgia, Delmonte, Angelo, Scartozzi, Mario, Loretelli, Cristian, Lucchesi, Alessandro, Oboldi, Devil, Dubini, Alessandra, Frassineti, Giovanni Luca, Ulivi, Paola
Publicado no BMC Cancer (2016)

Prognostic role of serum concentrations of high-sensitivity C-reactive protein in patients with metastatic colorectal cancer: results from the ITACa trial

Por Gardini, Andrea Casadei, Carloni, Silvia, Scarpi, Emanuela, Maltoni, Paolo, Dorizzi, Romolo M., Passardi, Alessandro, Frassineti, Giovanni Luca, Cortesi, Pietro, Giannini, Maria Benedetta, Marisi, Giorgia, Amadori, Dino, Lucchesi, Alessandro
Publicado no Oncotarget (2016)

Appropriate use of tumour biomarkers for treatment with innovative drugs: A retrospective study

Por MASSA, ILARIA, NANNI, ORIANA, GUIDOBONI, MASSIMO, FRASSINETI, GIOVANNI LUCA, ROCCA, ANDREA, BURGIO, MARCO ANGELO, VALMORRI, LINDA, MARRI, MATTIA, PIANCASTELLI, ALESSANDRA, FAEDI, MARINA, LEONI, MAURIZIO, TAMBERI, STEFANO, ALTINI, MATTIA, AMADORI, DINO
Publicado no Oncol Lett (2016)

Immune inflammation indicators and implication for immune modulation strategies in advanced hepatocellular carcinoma patients receiving sorafenib

Por Gardini, Andrea Casadei, Scarpi, Emanuela, Faloppi, Luca, Scartozzi, Mario, Silvestris, Nicola, Santini, Daniele, de Stefano, Giorgio, Marisi, Giorgia, Negri, Francesca V., Foschi, Francesco Giuseppe, Valgiusti, Martina, Ercolani, Giorgio, Frassineti, Giovanni Luca
Publicado no Oncotarget (2016)

Predictive role of multiple gene alterations in response to cetuximab in metastatic colorectal cancer: A single center study

Por Ulivi, Paola, Capelli, Laura, Valgiusti, Martina, Zoli, Wainer, Scarpi, Emanuela, Chiadini, Elisa, Rosetti, Paola, Bravaccini, Sara, Calistri, Daniele, Saragoni, Luca, Casadei Gardini, Andrea, Ragazzini, Angela, Frassineti, Giovanni Luca, Amadori, Dino, Passardi, Alessandro
Publicado em 2012

Multicentric survey on dose reduction/interruption of cancer drug therapy in 12.472 patients: indicators of suspected adverse reactions

Por Gardini, Andrea Casadei, Tenti, Elena, Masini, Carla, Nanni, Oriana, Scarpi, Emanuela, Valgiusti, Martina, Restuccia, Silvia, Gallani, Maria Laura, Palazzini, Simonetta, Bianchini, Erica, Menozzi, Silvia, Maugeri, Antonio, Amadori, Dino, Minguzzi, Martina, Frassineti, Giovanni Luca
Publicado no Oncotarget (2016)

Metronomic capecitabine versus best supportive care as second-line treatment in hepatocellular carcinoma: a retrospective study

Por Casadei Gardini, Andrea, Foca, Flavia, Scartozzi, Mario, Silvestris, Nicola, Tamburini, Emiliano, Faloppi, Luca, Brunetti, Oronzo, Rudnas, Britt, Pisconti, Salvatore, Valgiusti, Martina, Marisi, Giorgia, Foschi, Francesco Giuseppe, Ercolani, Giorgio, Tassinari, Davide, Cascinu, Stefano, Frassineti, Giovanni Luca
Publicado no Sci Rep (2017)

Early onset of hypertension and serum electrolyte changes as potential predictive factors of activity in advanced HCC patients treated with sorafenib: results from a retrospective...

Por Gardini, Andrea Casadei, Scarpi, Emanuela, Marisi, Giorgia, Foschi, Francesco Giuseppe, Donati, Gabriele, Giampalma, Emanuela, Faloppi, Luca, Scartozzi, Mario, Silvestris, Nicola, Bisulli, Marcello, Corbelli, Jody, Gardini, Andrea, Barba, Giuliano La, Veneroni, Luigi, Tamberi, Stefano, Cascinu, Stefano, Frassineti, Giovanni Luca
Publicado no Oncotarget (2016)

eNOS polymorphisms and clinical outcome in advanced HCC patients receiving sorafenib: final results of the ePHAS study

Por Gardini, Andrea Casadei, Marisi, Giorgia, Faloppi, Luca, Scarpi, Emanuela, Foschi, Francesco Giuseppe, Iavarone, Massimo, Lauletta, Gianfranco, Corbelli, Jody, Valgiusti, Martina, Facchetti, Floriana, Corte, Cristina della, Neri, Luca Maria, Tamberi, Stefano, Cascinu, Stefano, Scartozzi, Mario, Amadori, Dino, Nanni, Oriana, Tenti, Elena, Ulivi, Paola, Frassineti, Giovanni Luca
Publicado no Oncotarget (2016)